79332314 - LIVITECH

Information

• Trademark
• 79332314

• Source

• Serial Number

  79332314

• Registration Number

  7117212

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  December 02, 2021
  3 years ago

• Registration Date

  July 25, 2023
  a year ago

• Transaction Date

  November 21, 2023
  a year ago

• Status Date

  July 25, 2023
  a year ago

• Published for Opposition Date

  May 09, 2023
  a year ago

• Location Date

  July 25, 2023
  a year ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  MCGILL, CIERRA L

• Attorney Docket Number

  N&P-51854

  Attorney Name

  Ronald M. Kachmarik

  Law Office Assigned Location Code

  M10

• Owners

  • GENFIT

Case File Statements

• DM0000: The mark consists of the stylized wording "LIVITECH" with the letters "LIVI" in dark blue and the word "TECH" in light blue, all to the right of a design of twelve tilted squares with six tilted squares in light blue and six tilted squares in dark blue with the four largest tilted squares in the center connected by straight lines to a smaller tilted square each, with two of the lines in dark blue and two of the lines in light blue. The gray background behind the tilted square design represents shading and/or transparent and is not a feature of the mark.
• GS0091: Downloadable software for use in diagnosis of inflammatory diseases and liver diseases; downloadable software applications for use in diagnosing medical conditions; scientific apparatus and instruments especially for recording, processing, reproducing, transmitting data, namely, electronic data loggers and recorders; data processing equipment; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
• GS0051: Pharmaceuticals for use in human or veterinary medicine, for scientific use for the treatment of inflammatory diseases and liver diseases; chemical preparations for use in human or veterinary medicine, or for pharmaceutical use, namely, for the treatment of inflammatory diseases and liver diseases; biological preparations for use in human or veterinary medicine, or for pharmaceutical use, namely, for the treatment of inflammatory diseases and liver diseases; preparations for use in human or veterinary medicine, or for pharmaceutical use, namely, for the treatment of inflammatory diseases and liver diseases; microorganism cultures for use in human or veterinary medicine, or for pharmaceutical use; cell preparations for use in human or veterinary medicine, or for pharmaceutical use, in particular for gene therapy and cell therapy, namely, cell growth media; blood and blood derived samples, namely plasma, serum, platelet free samples for medical use; diagnostic biomarker reagent products for use in human or veterinary medicine; diagnostic reagents for use in human or veterinary medicine; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
• CC0000: The color(s) dark blue pantone n°288 c and light blue pantone n°3115 c is/are claimed as a feature of the mark.
• GS0011: Reagents for chemical analyses for scientific use; reagents for scientific use; reagents for scientific or medical research use; diagnostic reagents for scientific use; reagents for immunoserology and molecular diagnosis for research use; chemical reagents for genetic research; in-vivo diagnostic reagents for scientific use; diagnostic reagents for scientific use or for research use; diagnostic reagents for in-vitro use in biochemistry, molecular biology, clinical chemistry and microbiology for research use; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
• GS0441: Medical analysis relating to the diagnosis and treatment of persons and medical diagnosis services in inflammatory diseases and liver diseases; medical analyses of blood samples, biological preparations and biological fluids relating to the diagnosis and treatment of persons; support services in the field of medicine, health care and pharmaceutical research, namely, medical analysis for the diagnosis and treatment of patients; medical information; provision of medical information; all these services exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
• GS0101: Medical apparatus, instruments and equipment, namely, DNA, RNA and protein analysis apparatus, DNA, RNA and protein quantifiers, medical devices for measuring DNA, RNA, biochemical and physical parameters, namely concentration of biomarkers relating to the evaluation of inflammatory and liver diseases and blood analyzers for evaluation of inflammatory and liver diseases; instruments and tools for medical diagnosis, namely, computer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus during the process of diagnosis of a condition in an individual; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for testing the biomarker levels; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
• GS0421: Pharmaceutical research, namely, research for the discovery of new medicines; scientific research, especially in the medical, biomedical, chemical, genetic, pharmaceutical field; basic and applied scientific research; technical scientific research; scientific research, namely, sorting and selection of molecules; scientific research services, namely, development and validation of biological tests, cellular tests and genetic tests; scientific research, namely, functional genomics for identifying, characterizing, validating and developing biologically active molecules; analysis of biological substances in biological fluids; computer programming in the field of scientific research and for the pharmaceutical industry; engineering services, namely, surveying; technical project study being scientific research; professional consultancy unrelated to business dealings in the field of scientific and medical research; research and development of new pharmaceutical products for others; scientific research in the field of pharmacy; all these services exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public

Case File Event Statements

• 11/21/2023 - a year ago

  44 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 10/26/2023 - a year ago

  43 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 10/25/2023 - a year ago

  42 - FINAL DISPOSITION PROCESSED Type: FIMP

• 10/25/2023 - a year ago

  41 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 7/25/2023 - a year ago

  40 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 7/25/2023 - a year ago

  39 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 7/25/2023 - a year ago

  38 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 7/5/2023 - a year ago

  37 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 7/5/2023 - a year ago

  36 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 5/10/2023 - a year ago

  35 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 5/9/2023 - a year ago

  34 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/9/2023 - a year ago

  33 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/19/2023 - 2 years ago

  32 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 4/19/2023 - 2 years ago

  31 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 4/19/2023 - 2 years ago

  30 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/3/2023 - 2 years ago

  29 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/30/2023 - 2 years ago

  28 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/29/2023 - 2 years ago

  27 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/29/2023 - 2 years ago

  26 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/29/2023 - 2 years ago

  25 - REFUSAL PROCESSED BY IB Type: RFNT

• 3/1/2023 - 2 years ago

  24 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/1/2023 - 2 years ago

  23 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/1/2023 - 2 years ago

  22 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/26/2023 - 2 years ago

  21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/25/2023 - 2 years ago

  20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/25/2023 - 2 years ago

  19 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 1/17/2023 - 2 years ago

  18 - ASSIGNED TO EXAMINER Type: DOCK

• 1/2/2023 - 2 years ago

  17 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 1/2/2023 - 2 years ago

  16 - FINAL REFUSAL E-MAILED Type: GNFR

• 1/2/2023 - 2 years ago

  15 - FINAL REFUSAL WRITTEN Type: CNFR

• 11/27/2022 - 2 years ago

  14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/27/2022 - 2 years ago

  13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/24/2022 - 2 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/24/2022 - 2 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/24/2022 - 2 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 5/25/2022 - 2 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 4/29/2022 - 2 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 4/29/2022 - 2 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 3/18/2022 - 3 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 3/17/2022 - 3 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/17/2022 - 3 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 2/8/2022 - 3 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 2/4/2022 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 2/3/2022 - 3 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR